The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overexpression of the wild-type TP53 gene in cells effectively suppressed the transforming effects exerted on cells by those oncogenes, such as the MYC gene and RAS”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Coactivator condensation at super-enhancers links phase separation and gene control
Sabari, B. R., Dall’Agnese, A., Boija, A., Klein, I. A., Coffey, E. L., Shrinivas, K., Abraham, B. J., Hannett, N. M., Zamudio, A. V., Manteiga, J. C., et al. (2018) · Science · doi:10.1126/science.aar3958 · Cited by 2,595
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Engreitz, J. M., Haines, J. E., Perez, E. M., Munson, G., Chen, J., Kane, M., McDonel, P. E., Guttman, M., & Lander, E. S. (2016) · Nature · doi:10.1038/nature20149 · Cited by 1,253
CRISPR-mediated direct mutation of cancer genes in the mouse liver
Xue, W., Chen, S., Yin, H., Tammela, T., Papagiannakopoulos, T., Joshi, N. S., Cai, W., Yang, G., Bronson, R., Crowley, D. G., et al. (2014) · Nature · doi:10.1038/nature13589 · Cited by 776
Quantitative analysis of chromosome conformation capture assays (3C-qPCR)
Hagège, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W., & Forné, T. (2007) · Nature Protocols · doi:10.1038/nprot.2007.243 · Cited by 720 · cited 1×
“Chromosome Conformation Capture (3C)—Chromosome conformation capture was performed as described previously with minor modifications (Hagege et al., 2007).”
Classification of Proliferative Pulmonary Lesions of the Mouse
Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3376 · Cited by 334
Research works printed but not linked: 55
- Anders, 2015, HTSeq—a Python framework to work with high-throughput sequencing data, Bioinformatics, 31, 166, 10.1093/bioinformatics/btu638 · DOI · Paper page
- Barsotti, 2012, p53-dependent induction of PVT1 and miR-1204, J. Biol. Chem., 287, 2509, 10.1074/jbc.M111.322875 · DOI · Paper page
- Bassett, 2014, Considerations when investigating lncRNA function in vivo, eLife, 3, e03058, 10.7554/eLife.03058 · DOI · Paper page
- Chaumeil, 2008, Combined immunofluorescence, RNA fluorescent in situ hybridization, and DNA fluorescent in situ hybridization to study chromatin changes, transcriptional activity, nuclear organization, and X-chromosome inactivation, Methods Mol. Biol., 463, 297, 10.1007/978-1-59745-406-3_18 · DOI
- Cho, 2018, Promoter of lncRNA gene PVT1 is a tumor-suppressor DNA boundary element, Cell, 173, 1398, 10.1016/j.cell.2018.03.068 · DOI · Paper page
- Clarke, 1994, p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following gamma-irradiation, Oncogene, 9, 1767
- Conrad, 2017, Cellular fractionation and isolation of chromatin-associated RNA, Methods Mol. Biol., 1468, 1, 10.1007/978-1-4939-4035-6_1 · DOI
- Cory, 1985, Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene, EMBO J., 4, 675, 10.1002/j.1460-2075.1985.tb03682.x · DOI · Paper page
- Cui, 2016, Long non-coding RNA PVT1 and cancer, Biochem. Biophys. Res. Commun., 471, 10, 10.1016/j.bbrc.2015.12.101 · DOI
- Dahlman, 2015, Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease, Nat. Biotechnol., 33, 1159, 10.1038/nbt.3390 · DOI · Paper page
- Dimitrova, 2014, LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint, Mol. Cell, 54, 777, 10.1016/j.molcel.2014.04.025 · DOI · Paper page
- Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
- DuPage, 2009, Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase, Nat. Protoc., 4, 1064, 10.1038/nprot.2009.95 · DOI · Paper page
- Elling, 2018, Genetic models reveal cis and trans immune-regulatory activities for lincRNA-Cox2, Cell Rep., 25, 1511, 10.1016/j.celrep.2018.10.027 · DOI
- Engeland, 2018, Cell cycle arrest through indirect transcriptional repression by p53: I have a DREAM, Cell Death Differ., 25, 114, 10.1038/cdd.2017.172 · DOI · Paper page
- Feldser, 2010, Stage-specific sensitivity to p53 restoration during lung cancer progression, Nature, 468, 572, 10.1038/nature09535 · DOI · Paper page
- Graham, 1986, Chromosome 8 breakpoint far 3′ of the c-myc oncogene in a Burkitt’s lymphoma 2;8 variant translocation is equivalent to the murine pvt-1 locus, EMBO J., 5, 2845, 10.1002/j.1460-2075.1986.tb04578.x · DOI
- Graham, 1985, Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations, Nature, 314, 740, 10.1038/314740a0 · doi:10.1038/314740a0
- Groff, 2016, In vivo characterization of linc-p21 reveals functional cis-regulatory DNA elements, Cell Rep., 16, 2178, 10.1016/j.celrep.2016.07.050 · DOI
- Guan, 2007, Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer, Clin. Cancer Res., 13, 5745, 10.1158/1078-0432.CCR-06-2882 · DOI · Paper page
- Guo, 2018, Long noncoding RNA PVT1 modulates hepatocellular carcinoma cell proliferation and apoptosis by recruiting EZH2, Cancer Cell Int., 18, 98, 10.1186/s12935-018-0582-3 · DOI
- Ho, 2005, p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest, Mol. Cell. Biol., 25, 7423, 10.1128/MCB.25.17.7423-7431.2005 · DOI · Paper page
- Iwakawa, 2013, Genome-wide identification of genes with amplification and/or fusion in small cell lung cancer, Genes Chromosomes Cancer, 52, 802, 10.1002/gcc.22076 · DOI
- Jackson, 2001, Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras, Genes Dev., 15, 3243, 10.1101/gad.943001 · DOI · Paper page
- Jackson, 2005, The differential effects of mutant p53 alleles on advanced murine lung cancer, Cancer Res., 65, 10280, 10.1158/0008-5472.CAN-05-2193 · DOI · Paper page
- Kim, 2014, Novel fusion transcripts in human gastric cancer revealed by transcriptome analysis, Oncogene, 33, 5434, 10.1038/onc.2013.490 · DOI
- Kim, 2015, HISAT: a fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 · DOI · Paper page
- Kong, 2015, Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16, Mol. Cancer, 14, 82, 10.1186/s12943-015-0355-8 · DOI · Paper page
- Kopp, 2018, Functional classification and experimental dissection of long noncoding RNAs, Cell, 172, 393, 10.1016/j.cell.2018.01.011 · DOI · Paper page
- Kotzin, 2016, The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan, Nature, 537, 239, 10.1038/nature19346 · DOI · Paper page
- Lee, 2012, Epigenetic regulation by long noncoding RNAs, Science, 338, 1435, 10.1126/science.1231776 · DOI · Paper page
- Levy, 1993, Complementation by wild-type p53 of interleukin-6 effects on M1 cells: induction of cell cycle exit and cooperativity with c-myc suppression, Mol. Cell. Biol., 13, 7942
- Li, 2009, The Sequence Alignment/Map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
- Lin, 2012, Transcriptional amplification in tumor cells with elevated c-Myc, Cell, 151, 56, 10.1016/j.cell.2012.08.026 · DOI · Paper page
- Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol., 15, 550, 10.1186/s13059-014-0550-8 · DOI · Paper page
- Nagoshi, 2012, Frequent PVT1 rearrangement and novel chimeric genes PVT1-NBEA and PVT1-WWOX occur in multiple myeloma with 8q24 abnormality, Cancer Res., 72, 4954, 10.1158/0008-5472.CAN-12-0213 · DOI
- Northcott, 2012, Subgroup-specific structural variation across 1,000 medulloblastoma genomes, Nature, 488, 49, 10.1038/nature11327 · DOI · Paper page
- Pertea, 2015, StringTie enables improved reconstruction of a transcriptome from RNA-seq reads, Nat. Biotechnol., 33, 290, 10.1038/nbt.3122 · DOI · Paper page
- Platt, 2014, CRISPR-Cas9 knockin mice for genome editing and cancer modeling, Cell, 159, 440, 10.1016/j.cell.2014.09.014 · DOI · Paper page
- Porter, 2017, Global inhibition with specific activation: how p53 and MYC redistribute the transcriptome in the DNA double-strand break response, Mol. Cell, 67, 1013, 10.1016/j.molcel.2017.07.028 · DOI
- Riquelme, 2014, Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma, J. Thorac. Oncol., 9, 998, 10.1097/JTO.0000000000000202 · DOI
- Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- Sachdeva, 2009, p53 represses c-Myc through induction of the tumor suppressor miR-145, Proc. Natl. Acad. Sci. U S A, 106, 3207, 10.1073/pnas.0808042106 · DOI · Paper page
- Schofield, 2018, TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding, Nat. Methods, 15, 221, 10.1038/nmeth.4582 · DOI · Paper page
- Stewart, 2003, Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, 9, 493, 10.1261/rna.2192803 · DOI · Paper page
- Trapnell, 2009, TopHat: discovering splice junctions with RNA-Seq, Bioinformatics, 25, 1105, 10.1093/bioinformatics/btp120 · DOI · Paper page
- Tseng, 2015, The PVT1-MYC duet in cancer, Mol. Cell. Oncol., 2, e974467, 10.4161/23723556.2014.974467 · DOI
- Tseng, 2014, PVT1 dependence in cancer with MYC copy-number increase, Nature, 512, 82, 10.1038/nature13311 · DOI · Paper page
- Xu, 2012, FastUniq: a fast de novo duplicates removal tool for paired short reads, PLoS ONE, 7, e52249, 10.1371/journal.pone.0052249 · DOI · Paper page
- Xu, 2017, A positive feedback loop of lncRNA-PVT1 and FOXM1 facilitates gastric cancer growth and invasion, Clin. Cancer Res., 23, 2071, 10.1158/1078-0432.CCR-16-0742 · DOI · Paper page
- Zeng, 2017, LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis, Oncotarget, 8, 75455, 10.18632/oncotarget.20634 · DOI
- Zhang, 2019, Long non-coding RNA PVT1 promotes glioma cell proliferation and invasion by targeting miR-200a, Exp. Ther. Med., 17, 1337
- Zhao, 2018, LncRNA-PVT1 promotes pancreatic cancer cells proliferation and migration through acting as a molecular sponge to regulate miR-448, J. Cell. Physiol., 233, 4044, 10.1002/jcp.26072 · DOI
- Zheng, 2016, High expression of lncRNA PVT1 promotes invasion by inducing epithelial-to-mesenchymal transition in esophageal cancer, Oncol. Lett., 12, 2357, 10.3892/ol.2016.5026 · DOI
- Zhu, 2017, Prognostic value of long non-coding RNA PVT1 as a novel biomarker in various cancers: a meta-analysis, Oncotarget, 8, 113174, 10.18632/oncotarget.22830 · doi:10.18632/oncotarget.22830
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Yan, H., & Bu, P. (2021) · Essays in Biochemistry · doi:10.1042/ebc20200032 · Cited by 667
Metadata
- Authors
- Olivero, C. E., Martínez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., Schofield, J. A., Bendor, J., Fang, D., Simon, M. D., Zamudio, J. R., & Dimitrova, N.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 77
- Issue
- 4
- Pages
- 761-774.e8
- ISSN
- 1097-2765
- Cited by
- 145
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 385 d)
- Funders
- American Cancer Society (IRG-ACS 58-012-58)
- National Institutes of Health
- National Cancer Institute (R37CA230580)
- Yale University (T32GM007223)
- V Foundation for Cancer Research
- Lung Cancer Research Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis. https://app.cochat.ai/papers/10.1016/j.molcel.2019.12.014
- The paper
- Olivero, C. E., Martínez-Terroba, E., Zimmer, J., Liao, C., Tesfaye, E., Hooshdaran, N., Schofield, J. A., Bendor, J., Fang, D., Simon, M. D., Zamudio, J. R., & Dimitrova, N. (2020). p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis. Molecular Cell. https://doi.org/10.1016/j.molcel.2019.12.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.